Senior Adviser since 2026

Born in 1971. Licensed physician and MD, PhD. John has extensive knowledge and experience in drug development across several therapeutic areas, including CNS disorders, oncology and hematology. He has held senior positions in clinical research at AstraZeneca, Shire Pharmaceuticals and Medivir. John is also CEO of Modus Therapeutics. Before entering the pharmaceutical industry, he held various research and clinical positions at Lund University, Karolinska Institutet and Karolinska University Hospital.

No shareholding in KDventures.